fluorodeoxyglucose f18 has been researched along with Carcinoid Heart Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brouwers, AH; de Vries, EG; Fiebrich, HB; Links, TP | 1 |
| Calafiore, P; Lu, KJ; Rathi, V; Smith, G; Srivastava, PM | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Carcinoid Heart Disease
| Article | Year |
|---|---|
Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography.
Topics: Carcinoid Heart Disease; Carcinoid Tumor; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Multimodality imaging in an unusual case of palpitations and right heart failure.
Topics: Aged; Carcinoid Heart Disease; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Failure; Heart Neoplasms; Humans; Hydroxyindoleacetic Acid; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography; Ultrasonography | 2011 |